News

A collaborative research team has successfully developed a novel fluorescent probe, SLY (Sialyl Lewis Yellow), capable of ...
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...
The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells ...
Molecular vibrations, when paired with near-infrared (NIR) light, have opened a new chapter in cancer treatment. Instead of ...
Cancer cells can acquire energy-generating structures called mitochondria from nearby nerve cells, which seems to aid their ...
The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...
In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...
Could a legendary tomb curse become a medical miracle? Scientists may have reengineered Aspergillus flavus, linked to King ...
Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...
Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...
T cell-based immunotherapy, a form of cancer treatment, harnesses a patient’s own T cells — white blood cells that help fight ...
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates ...